Compounds > bucladesine

bucladesine and Psoriasis

bucladesine has been researched along with Psoriasis in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (87.50)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukuda, Y; Goto, M; Hayashi, Y; Inoue, H; Kadoshima-Yamaoka, K; Kanki, S; Murafuji, H; Murakawa, M; Nagahira, K; Nakatsuka, T; Ogata, A; Tanaka, Y; Yoshioka, R	1
Duell, EA; Voorhees, JJ	1
Delescluse, C; Pruniéras, M; Regnier, M	1
Cehovic, G; Laugier, P; Orusco, M; Posternak, F; Posternak, T	1
Bass, LJ; Duell, EA; Harrell, ER; Voorhees, JJ	1
Chopra, DP; Flaxman, BA; Harper, RA	1

Reviews

2 review(s) available for bucladesine and Psoriasis

Article	Year
The culture of skin. A review of theories and experimental methods. The Journal of investigative dermatology, 1976, Volume: 67, Issue:1 Topics: Amino Acids; Animals; Bucladesine; Cytological Techniques; Depression, Chemical; DNA, Neoplasm; DNA, Viral; Humans; Mitosis; Organ Culture Techniques; Psoriasis; Skin; Skin Neoplasms	1976
Role of cyclic AMP in the control of epidermal cell growth and differentiation. National Cancer Institute monograph, 1973, Volume: 38 Topics: Adenylyl Cyclases; Animals; Bucladesine; Cell Differentiation; Cell Division; Cyclic AMP; DNA; Epinephrine; Glycogen; Growth Inhibitors; Humans; Isoproterenol; Mitosis; Organ Specificity; Psoriasis; Skin; Theophylline; Time Factors; Wounds and Injuries	1973

Trials

1 trial(s) available for bucladesine and Psoriasis

Article	Year
[Trial treatment of psoriasis by intralesional injections of AMPc, 8-thio-dibutyryl AMPc and theophylline]. Annales de dermatologie et de syphiligraphie, 1976, Volume: 103, Issue:5-6 Topics: Administration, Topical; Bucladesine; Clinical Trials as Topic; Cyclic AMP; Female; Humans; Injections; Male; Psoriasis; Theophylline	1976

Other Studies

5 other study(ies) available for bucladesine and Psoriasis

Article	Year
Phosphodiesterase 7A inhibitor ASB16165 impairs proliferation of keratinocytes in vitro and in vivo. European journal of pharmacology, 2010, May-10, Volume: 633, Issue:1-3 Topics: Administration, Cutaneous; Animals; Bucladesine; Cell Proliferation; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 7; Disease Models, Animal; Epidermis; Female; Humans; Keratinocytes; Mice; Mice, Inbred BALB C; Phosphodiesterase Inhibitors; Psoriasis; Pyrazoles; Skin; Tetradecanoylphorbol Acetate; Thiophenes	2010
Imbalanced cyclic AMP-cyclic GMP levels in psoriasis. Advances in cyclic nucleotide research, 1975, Volume: 5 Topics: Animals; Bucladesine; Cell Differentiation; Cell Division; Cells, Cultured; Cyclic AMP; Cyclic GMP; DNA; Glycogen; Humans; Mice; Papaverine; Psoriasis; Skin; Theophylline; Xanthines	1975
Cyclic AMP and dibutyryl AMP in treatment of psoriasis. Chinese medical journal, 1976, Volume: 2, Issue:2 Topics: Adolescent; Adult; Aged; Bucladesine; Child; Cyclic AMP; Female; Humans; Male; Middle Aged; Psoriasis	1976
Mitotic response of normal and psoriatic keratinocytes in vitro to compounds known to affect intracellular cyclic AMP. The Journal of investigative dermatology, 1974, Volume: 62, Issue:4 Topics: Bucladesine; Cells, Cultured; Cyclic AMP; Epinephrine; Epithelial Cells; Epithelium; Fluorides; Histamine; Humans; In Vitro Techniques; Isoproterenol; Keratins; Mitosis; Psoriasis; Theophylline	1974
[Clinical observations on dibutyryl cyclic AMP in the treatment of psoriasis]. Zhonghua yi xue za zhi, 1974, Volume: 4 Topics: Adolescent; Adult; Bucladesine; Child; Female; Humans; Male; Psoriasis	1974